HilleVax, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
HilleVax, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2021 to Q3 2024.
  • HilleVax, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $557K, a 73.4% decline year-over-year.
  • HilleVax, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $9.15M, a 9.48% increase year-over-year.
  • HilleVax, Inc. annual Nonoperating Income (Expense) for 2023 was $9.78M.
  • HilleVax, Inc. annual Nonoperating Income (Expense) for 2022 was -$94.7M, a 93.3% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $9.15M $557K -$1.54M -73.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $10.7M $2.3M +$13K +0.57% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $10.7M $2.97M +$898K +43.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $9.78M $3.33M +$1.42M +74.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 $8.36M $2.1M +$1.01M +92.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $7.35M $2.28M +$43.4M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$36.1M $2.07M +$58.6M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$94.7M $1.91M +$28.2M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 -$123M $1.09M +$23.3M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$146M -$41.1M -$40.7M -8957% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$105M -$56.6M -$56.5M -69743% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$49M -$26.3M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 -$22.2M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$454K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$81K Jan 1, 2021 Mar 31, 2021 10-Q 2022-06-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.